-
1
-
-
0036229026
-
Structural basis of T cell recognition of peptides bound to MHC molecules
-
Wang JH and Reinherz EL: Structural basis of T cell recognition of peptides bound to MHC molecules. Mol Immunol 38:1039-1049, 2002.
-
(2002)
Mol Immunol
, vol.38
, pp. 1039-1049
-
-
Wang, J.H.1
Reinherz, E.L.2
-
2
-
-
20544463394
-
Antigen processing is predictable: From genes to T cell epitopes
-
Stevanovic S: Antigen processing is predictable: From genes to T cell epitopes. Transpl Immunol 14:171-174, 2005.
-
(2005)
Transpl Immunol
, vol.14
, pp. 171-174
-
-
Stevanovic, S.1
-
3
-
-
33845867675
-
Direct class I HLA antigen discovery to distinguish virus-infected and cancerous cells
-
Wahl A, Weidanz J and Hildebrand W: Direct class I HLA antigen discovery to distinguish virus-infected and cancerous cells. Expert Rev Proteomics 3:641-652, 2006.
-
(2006)
Expert Rev Proteomics
, vol.3
, pp. 641-652
-
-
Wahl, A.1
Weidanz, J.2
Hildebrand, W.3
-
4
-
-
12944325331
-
A listing of human tumor antigens recognized by T cells: March 2004 update
-
Novellino L, Castelli C and Parmiani G: A listing of human tumor antigens recognized by T cells: March 2004 update. Cancer Immunol Immunother 54:187-207, 2005.
-
(2005)
Cancer Immunol Immunother
, vol.54
, pp. 187-207
-
-
Novellino, L.1
Castelli, C.2
Parmiani, G.3
-
5
-
-
0035902080
-
Progress in human tumour immunology and immunotherapy
-
Rosenberg SA: Progress in human tumour immunology and immunotherapy. Nature 411:380-384, 2001.
-
(2001)
Nature
, vol.411
, pp. 380-384
-
-
Rosenberg, S.A.1
-
6
-
-
84255197842
-
Cancer immunotherapy comes of age
-
Mellman I, Coukos G and Dranoff G: Cancer immunotherapy comes of age. Nature 480:480-489, 2011.
-
(2011)
Nature
, vol.480
, pp. 480-489
-
-
Mellman, I.1
Coukos, G.2
Dranoff, G.3
-
8
-
-
0034669973
-
Generation of T cells specific for the wild-type sequence p53 (264-272) peptide in cancer patients: Implications for immunoselection of epitope loss variants
-
Hoffmann TK, Nakano K, Elder EM, Dworacki G, Finkelstein SD, Appella E, Whiteside TL and DeLeo AB: Generation of T cells specific for the wild-type sequence p53 (264-272) peptide in cancer patients: implications for immunoselection of epitope loss variants. J Immunol 165:5938-5944, 2000.
-
(2000)
J Immunol
, vol.165
, pp. 5938-5944
-
-
Hoffmann, T.K.1
Nakano, K.2
Elder, E.M.3
Dworacki, G.4
Finkelstein, S.D.5
Appella, E.6
Whiteside, T.L.7
DeLeo, A.B.8
-
9
-
-
33644557403
-
∗0201 complexes naturally presented on tumor cell surface by a multimeric soluble single-chain T cell receptor
-
∗0201 complexes naturally presented on tumor cell surface by a multimeric soluble single-chain T cell receptor. J Immunol 176:3223-3232, 2006.
-
(2006)
J Immunol
, vol.176
, pp. 3223-3232
-
-
Zhu, X.1
Belmont, H.J.2
Price-Schiavi, S.3
Liu, B.4
Lee, H.I.5
Fernandez, M.6
Wong, R.L.7
Builes, J.8
Rhode, P.R.9
Wong, H.C.10
-
10
-
-
52549111166
-
Targeting activity of a TCR/IL-2 fusion protein against established tumors
-
Wen J, Zhu X, Liu B, You L, Kong L, Lee HI, Han KP, Wong JL, Rhode PR and Wong HC: Targeting activity of a TCR/IL-2 fusion protein against established tumors. Cancer Immunol Immunother 57:1781-1794, 2008.
-
(2008)
Cancer Immunol Immunother
, vol.57
, pp. 1781-1794
-
-
Wen, J.1
Zhu, X.2
Liu, B.3
You, L.4
Kong, L.5
Lee, H.I.6
Han, K.P.7
Wong, J.L.8
Rhode, P.R.9
Wong, H.C.10
-
11
-
-
33748625158
-
Potent antitumor activity of a tumorspecific soluble TCR/IL-2 fusion protein
-
Belmont HJ, Price-Schiavi S, Liu B, Card KF, Lee HI, Han KP, Wen J, Tang S, Zhu X, Merrill J, Chavillaz PA, Wong JL, Rhode PR and Wong HC: Potent antitumor activity of a tumorspecific soluble TCR/IL-2 fusion protein. Clin Immunol 121:29-39, 2006.
-
(2006)
Clin Immunol
, vol.121
, pp. 29-39
-
-
Belmont, H.J.1
Price-Schiavi, S.2
Liu, B.3
Card, K.F.4
Lee, H.I.5
Han, K.P.6
Wen, J.7
Tang, S.8
Zhu, X.9
Merrill, J.10
Chavillaz, P.A.11
Wong, J.L.12
Rhode, P.R.13
Wong, H.C.14
-
12
-
-
12144290526
-
A soluble singlechain T cell receptor IL-2 fusion protein retains MHC-restricted peptide specificity and IL-2 bioactivity
-
Card KF, Price-Schiavi SA, Liu B, Thomson E, Nieves E, Belmont H, Builes J, Jiao JA, Hernandez J, Weidanz J, Sherman L, Francis JL, Amirkhosravi A and Wong HC: A soluble singlechain T cell receptor IL-2 fusion protein retains MHC-restricted peptide specificity and IL-2 bioactivity. Cancer Immunol Immunother 53:345-3357, 2004.
-
(2004)
Cancer Immunol Immunother
, vol.53
, pp. 345-3357
-
-
Card, K.F.1
Price-Schiavi, S.A.2
Liu, B.3
Thomson, E.4
Nieves, E.5
Belmont, H.6
Builes, J.7
Jiao, J.A.8
Hernandez, J.9
Weidanz, J.10
Sherman, L.11
Francis, J.L.12
Amirkhosravi, A.13
Wong, H.C.14
-
13
-
-
84055212017
-
∗0201 complex, in patients with advanced malignancies
-
∗0201 complex, in patients with advanced malignancies. Clin Cancer Res 17:7765-7775, 2011.
-
(2011)
Clin Cancer Res
, vol.17
, pp. 7765-7775
-
-
Fishman, M.N.1
Thompson, J.A.2
Pennock, G.K.3
Gonzalez, R.4
Diez, L.M.5
Daud, A.I.6
Weber, J.S.7
Huang, B.Y.8
Tang, S.9
Rhode, P.R.10
Wong, H.C.11
-
14
-
-
84055212017
-
∗0201 complex, in patients with advanced malignancies
-
∗0201 complex, in patients with advanced malignancies. Clin Cancer Res 17:7765-7775, 2011.
-
(2011)
Clin Cancer Res
, vol.17
, pp. 7765-7775
-
-
Fishman, M.N.1
Thompson, J.A.2
Pennock, G.K.3
Gonzalez, R.4
Diez, L.M.5
Daud, A.I.6
Weber, J.S.7
Huang, B.Y.8
Tang, S.9
Rhode, P.R.10
Wong, H.C.11
-
15
-
-
20144384733
-
In vitro and in vivo characterization of a novel antibody-like single-chain TCR human IgG1 fusion protein
-
Mosquera LA, Card KF, Price-Schiavi SA, Belmont HJ, Liu B, Builes J, Zhu X, Chavaillaz PA, Lee HI, Jiao JA, Francis JL, Amirkhosravi A, Wong RL and Wong HC: In vitro and in vivo characterization of a novel antibody-like single-chain TCR human IgG1 fusion protein. J Immunol 174:4381-4388, 2005.
-
(2005)
J Immunol
, vol.174
, pp. 4381-4388
-
-
Mosquera, L.A.1
Card, K.F.2
Price-Schiavi, S.A.3
Belmont, H.J.4
Liu, B.5
Builes, J.6
Zhu, X.7
Chavaillaz, P.A.8
Lee, H.I.9
Jiao, J.A.10
Francis, J.L.11
Amirkhosravi, A.12
Wong, R.L.13
Wong, H.C.14
-
16
-
-
84855804372
-
Interleukin-15 biology and its therapeutic implications in cancer
-
Steel JC, Waldmann TA and Morris JC: Interleukin-15 biology and its therapeutic implications in cancer. Trends Pharmacol Sci 33:35-41, 2012.
-
(2012)
Trends Pharmacol Sci
, vol.33
, pp. 35-41
-
-
Steel, J.C.1
Waldmann, T.A.2
Morris, J.C.3
-
17
-
-
84877865939
-
Efficacy and mechanism-of-action of a novel superagonist interleukin-15: Interleukin-15 receptor aSu/Fc fusion complex in syngeneic murine models of multiple myeloma
-
Xu W, Jones M, Liu B, Zhu X, Johnson CB, Edwards AC, Kong L, Jeng EK, Han K, Marcus WD, Rubinstein MP, Rhode PR and Wong HC: Efficacy and mechanism-of-action of a novel superagonist interleukin-15: interleukin-15 receptor aSu/Fc fusion complex in syngeneic murine models of multiple myeloma. Cancer Res 73:3075-3086, 2013.
-
(2013)
Cancer Res
, vol.73
, pp. 3075-3086
-
-
Xu, W.1
Jones, M.2
Liu, B.3
Zhu, X.4
Johnson, C.B.5
Edwards, A.C.6
Kong, L.7
Jeng, E.K.8
Han, K.9
Marcus, W.D.10
Rubinstein, M.P.11
Rhode, P.R.12
Wong, H.C.13
-
18
-
-
0027333418
-
Superantigens: Bacterial and viral proteins that manipulate the immune system
-
Scherer MT, Ignatowicz L, Winslow GM, Kappler JW and Marrack P: Superantigens: bacterial and viral proteins that manipulate the immune system. Annu Rev Cell Biol 9:101-128, 1993.
-
(1993)
Annu Rev Cell Biol
, vol.9
, pp. 101-128
-
-
Scherer, M.T.1
Ignatowicz, L.2
Winslow, G.M.3
Kappler, J.W.4
Marrack, P.5
-
19
-
-
0026077824
-
Staphylococcal enterotoxin microbial superantigens
-
Johnson HM, Russell JK and Pontzer CH: Staphylococcal enterotoxin microbial superantigens. FASEB J 5:2706-2712, 1991.
-
(1991)
FASEB J
, vol.5
, pp. 2706-2712
-
-
Johnson, H.M.1
Russell, J.K.2
Pontzer, C.H.3
-
21
-
-
0029854470
-
Immune response during tumor therapy with antibody-superantigen fusion proteins
-
Rosendahl A, Hansson J, Sundstedt A, Kalland T and Dohlsten M: Immune response during tumor therapy with antibody-superantigen fusion proteins. Int J Cancer 68:109-113, 1996.
-
(1996)
Int J Cancer
, vol.68
, pp. 109-113
-
-
Rosendahl, A.1
Hansson, J.2
Sundstedt, A.3
Kalland, T.4
Dohlsten, M.5
-
22
-
-
0031000834
-
Tumor therapy with an antibody-targeted superantigen generates a dichotomy between local and systemic immune responses
-
Litton MJ, Dohlsten M, Hansson J, Rosendahl A, Ohlsson L, Kalland T, Andersson J and Andersson U: Tumor therapy with an antibody-targeted superantigen generates a dichotomy between local and systemic immune responses. Am J Pathol 150:1607-1618, 1997.
-
(1997)
Am J Pathol
, vol.150
, pp. 1607-1618
-
-
Litton, M.J.1
Dohlsten, M.2
Hansson, J.3
Rosendahl, A.4
Ohlsson, L.5
Kalland, T.6
Andersson, J.7
Andersson, U.8
-
23
-
-
0028559775
-
Monoclonal antibody-superantigen fusion proteins: Tumorspecific agents for T cell-based tumor therapy
-
Dohlsten M, Abrahmsén L, Björk P, Lando PA, Hedlund G, Forsberg G, Brodin T, Gascoigne NR, Förberg C and Lind P: Monoclonal antibody-superantigen fusion proteins: tumorspecific agents for T cell-based tumor therapy. Proc Natl Acad Sci USA 91:8945-8949, 1994.
-
(1994)
Proc Natl Acad Sci USA
, vol.91
, pp. 8945-8949
-
-
Dohlsten, M.1
Abrahmsén, L.2
Björk, P.3
Lando, P.A.4
Hedlund, G.5
Forsberg, G.6
Brodin, T.7
Gascoigne, N.R.8
Förberg, C.9
Lind, P.10
-
25
-
-
0025060715
-
Isolation and characterization of 5T4, a tumor-associated antigen
-
Hole N and Stern PL: Isolation and characterization of 5T4, a tumor-associated antigen. Int J Cancer 45:179-184, 1990.
-
(1990)
Int J Cancer
, vol.45
, pp. 179-184
-
-
Hole, N.1
Stern, P.L.2
-
26
-
-
0025109257
-
Immunohistological distribution of 5T4 antigen in normal and malignant tissues
-
Southall PJ, Boxer GM, Bagshawe KD, Hole N, Bromley M and Stern PL: Immunohistological distribution of 5T4 antigen in normal and malignant tissues. Br J Cancer 61:89-95, 1990.
-
(1990)
Br J Cancer
, vol.61
, pp. 89-95
-
-
Southall, P.J.1
Boxer, G.M.2
Bagshawe, K.D.3
Hole, N.4
Bromley, M.5
Stern, P.L.6
-
27
-
-
0142185502
-
Identification of the antigenic epitopes in staphylococcal enterotoxins A and E and design of a superantigen for human cancer therapy
-
Erlandsson E, Andersson K, Cavallin A, Nilsson A, Larsson-Lorek U, Niss U, Sjöberg A, Wallén-Ohman M, Antonsson P, Walse B and Forsberg G: Identification of the antigenic epitopes in staphylococcal enterotoxins A and E and design of a superantigen for human cancer therapy. J Mol Biol 333:893-905, 2003.
-
(2003)
J Mol Biol
, vol.333
, pp. 893-905
-
-
Erlandsson, E.1
Andersson, K.2
Cavallin, A.3
Nilsson, A.4
Larsson-Lorek, U.5
Niss, U.6
Sjöberg, A.7
Wallén-Ohman, M.8
Antonsson, P.9
Walse, B.10
Forsberg, G.11
-
28
-
-
84886077915
-
The tumor targeted superantigen ABR-217620 selectively engages TRBV7-9 and exploits TCR-pMHC affinity mimicry in mediating T cell cytotoxicity
-
Hedlund G, Eriksson H, Sundstedt A, Forsberg G, Jakobsen BK, Pumphrey N, Rödström K, Lindkvist-Petersson K and Björk P: The tumor targeted superantigen ABR-217620 selectively engages TRBV7-9 and exploits TCR-pMHC affinity mimicry in mediating T cell cytotoxicity. PLoS One 8:e79082, 2013.
-
(2013)
PLoS One
, vol.8
, pp. e79082
-
-
Hedlund, G.1
Eriksson, H.2
Sundstedt, A.3
Forsberg, G.4
Jakobsen, B.K.5
Pumphrey, N.6
Rödström, K.7
Lindkvist-Petersson, K.8
Björk, P.9
-
29
-
-
0042971650
-
Molecular interactions mediating T cell antigen recognition
-
van der Merwe PA and Davis SJ: Molecular interactions mediating T cell antigen recognition. Annu Rev Immunol 21:659-684, 2003.
-
(2003)
Annu Rev Immunol
, vol.21
, pp. 659-684
-
-
Van Der Merwe, P.A.1
Davis, S.J.2
-
31
-
-
84862025335
-
Monoclonal TCR-redirected tumor cell killing
-
Liddy N, Bossi G, Adams KJ, Lissina A, Mahon TM, Hassan NJ, Gavarret J, Bianchi FC, Pumphrey NJ, Ladell K, Gostick E, Sewell AK, Lissin NM, Harwood NE, Molloy PE, Li Y, Cameron BJ, Sami M, Baston EE, Todorov PT, Paston SJ, Dennis RE, Harper JV, Dunn SM, Ashfield R, Johnson A, McGrath Y, Plesa G, June CH, Kalos M, Price DA, Vuidepot A, Williams DD, Sutton DH and Jakobsen BK: Monoclonal TCR-redirected tumor cell killing. Nat Med 18:980-987, 2012.
-
(2012)
Nat Med
, vol.18
, pp. 980-987
-
-
Liddy, N.1
Bossi, G.2
Adams, K.J.3
Lissina, A.4
Mahon, T.M.5
Hassan, N.J.6
Gavarret, J.7
Bianchi, F.C.8
Pumphrey, N.J.9
Ladell, K.10
Gostick, E.11
Sewell, A.K.12
Lissin, N.M.13
Harwood, N.E.14
Molloy, P.E.15
Li, Y.16
Cameron, B.J.17
Sami, M.18
Baston, E.E.19
Todorov, P.T.20
Paston, S.J.21
Dennis, R.E.22
Harper, J.V.23
Dunn, S.M.24
Ashfield, R.25
Johnson, A.26
McGrath, Y.27
Plesa, G.28
June, C.H.29
Kalos, M.30
Price, D.A.31
Vuidepot, A.32
Williams, D.D.33
Sutton, D.H.34
Jakobsen, B.K.35
more..
-
32
-
-
84886945598
-
ImmTACs: Novel bi-specific agents for targeted cancer therapy
-
Oates J and Jakobsen BK: ImmTACs: Novel bi-specific agents for targeted cancer therapy. Oncoimmunology 2: e22891, 2013.
-
(2013)
Oncoimmunology
, vol.2
, pp. e22891
-
-
Oates, J.1
Jakobsen, B.K.2
-
33
-
-
67449156132
-
Bispecific T cell engaging antibodies for cancer therapy
-
Baeuerle PA and Reinhardt C: Bispecific T cell engaging antibodies for cancer therapy. Cancer Res 69:4941-4944, 2009.
-
(2009)
Cancer Res
, vol.69
, pp. 4941-4944
-
-
Baeuerle, P.A.1
Reinhardt, C.2
-
34
-
-
68449086890
-
Immunotherapy of lymphoma and leukemia with T cell engaging BiTE antibody blinatumomab
-
Nagorsen D, Bargou R, Ruttinger D, Kufer P, Baeuerle PA and Zugmaier G: Immunotherapy of lymphoma and leukemia with T cell engaging BiTE antibody blinatumomab. Leuk Lymphoma 50:886-891, 2009.
-
(2009)
Leuk Lymphoma
, vol.50
, pp. 886-891
-
-
Nagorsen, D.1
Bargou, R.2
Ruttinger, D.3
Kufer, P.4
Baeuerle, P.A.5
Zugmaier, G.6
-
35
-
-
0142215405
-
Stable, soluble T cell receptor molecules for crystallization and therapeutics
-
Boulter JM, Glick M, Todorov PT, Baston E, Sami M, Rizkallah P and Jakobsen BK: Stable, soluble T cell receptor molecules for crystallization and therapeutics. Protein Eng 16:707-711, 2003.
-
(2003)
Protein Eng
, vol.16
, pp. 707-711
-
-
Boulter, J.M.1
Glick, M.2
Todorov, P.T.3
Baston, E.4
Sami, M.5
Rizkallah, P.6
Jakobsen, B.K.7
-
36
-
-
21444445173
-
Directed evolution of human T cell receptors with picomolar affinities by phage display
-
Li Y, Moysey R, Molloy PE, Vuidepot AL, Mahon T, Baston E, Dunn S, Liddy N, Jacob J, Jakobsen BK and Boulter JM: Directed evolution of human T cell receptors with picomolar affinities by phage display. Nat Biotechnol 23:349-354, 2005.
-
(2005)
Nat Biotechnol
, vol.23
, pp. 349-354
-
-
Li, Y.1
Moysey, R.2
Molloy, P.E.3
Vuidepot, A.L.4
Mahon, T.5
Baston, E.6
Dunn, S.7
Liddy, N.8
Jacob, J.9
Jakobsen, B.K.10
Boulter, J.M.11
-
37
-
-
0034624983
-
In vitro evolution of a T cell receptor with high affinity for peptide/MHC
-
Holler PD, Holman PO, Shusta EV, O'Herrin S, Wittrup KD and Kranz DM: In vitro evolution of a T cell receptor with high affinity for peptide/MHC. Proc Natl Acad Sci USA 97:5387-5392, 2000.
-
(2000)
Proc Natl Acad Sci USA
, vol.97
, pp. 5387-5392
-
-
Holler, P.D.1
Holman, P.O.2
Shusta, E.V.3
O'Herrin, S.4
Wittrup, K.D.5
Kranz, D.M.6
-
38
-
-
12344322695
-
High-affinity, peptide-specific T cell receptors can be generated by mutations in CDR1, CDR2 or CDR3
-
Chlewicki LK, Holler PD, Monti BC, Clutter MR and Kranz DM: High-affinity, peptide-specific T cell receptors can be generated by mutations in CDR1, CDR2 or CDR3. J Mol Biol 346:223-239, 2005.
-
(2005)
J Mol Biol
, vol.346
, pp. 223-239
-
-
Chlewicki, L.K.1
Holler, P.D.2
Monti, B.C.3
Clutter, M.R.4
Kranz, D.M.5
-
39
-
-
71049153709
-
Cancer/testis (CT) antigens: Potential targets for immunotherapy
-
Caballero OL and Chen YT: Cancer/testis (CT) antigens: potential targets for immunotherapy. Cancer Sci 100:2014-2021, 2009.
-
(2009)
Cancer Sci
, vol.100
, pp. 2014-2021
-
-
Caballero, O.L.1
Chen, Y.T.2
-
40
-
-
84862228799
-
Cancer-testis and melanocyte-differentiation antigen expression in malignant glioma and meningioma
-
Syed ON, Mandigo CE, Killory BD, Canoll P and Bruce JN: Cancer-testis and melanocyte-differentiation antigen expression in malignant glioma and meningioma. J Clin Neurosci 19:1016-1021, 2012.
-
(2012)
J Clin Neurosci
, vol.19
, pp. 1016-1021
-
-
Syed, O.N.1
Mandigo, C.E.2
Killory, B.D.3
Canoll, P.4
Bruce, J.N.5
-
42
-
-
84876330945
-
Gastrointestinal stromal tumors, somatic mutations and candidate genetic risk variants
-
O'Brien KM, Orlow I, Antonescu CR, Ballman K, McCall L, DeMatteo R and Engel LS: Gastrointestinal stromal tumors, somatic mutations and candidate genetic risk variants. PLoS One 8:e62119, 2013.
-
(2013)
PLoS One
, vol.8
, pp. e62119
-
-
O'Brien, K.M.1
Orlow, I.2
Antonescu, C.R.3
Ballman, K.4
McCall, L.5
DeMatteo, R.6
Engel, L.S.7
-
43
-
-
84877840760
-
Bi-specific TCR-anti CD3 redirected T cell targeting of NY-ESO-1- and LAGE-1-positive tumors
-
McCormack E, Adams KJ, Hassan NJ, Kotian A, Lissin NM, Sami M, Mujic M, Osdal T, Gjertsen BT, Baker D, Powlesland AS, Aleksic M, Vuidepot A, Morteau O, Sutton DH, June CH, Kalos M, Ashfield R and Jakobsen BK. Bi-specific TCR-anti CD3 redirected T cell targeting of NY-ESO-1- and LAGE-1-positive tumors. Cancer Immunol Immunother 62:773-785, 2013.
-
(2013)
Cancer Immunol Immunother
, vol.62
, pp. 773-785
-
-
McCormack, E.1
Adams, K.J.2
Hassan, N.J.3
Kotian, A.4
Lissin, N.M.5
Sami, M.6
Mujic, M.7
Osdal, T.8
Gjertsen, B.T.9
Baker, D.10
Powlesland, A.S.11
Aleksic, M.12
Vuidepot, A.13
Morteau, O.14
Sutton, D.H.15
June, C.H.16
Kalos, M.17
Ashfield, R.18
Jakobsen, B.K.19
-
44
-
-
0033924550
-
Functionally distinct CD8+ memory T cell subsets in persistent EBV infection are differentiated by migratory receptor expression
-
Tussey L, Speller S, Gallimore A and Vessey R: Functionally distinct CD8+ memory T cell subsets in persistent EBV infection are differentiated by migratory receptor expression. Eur J Immunol 30:1823-1829, 2000.
-
(2000)
Eur J Immunol
, vol.30
, pp. 1823-1829
-
-
Tussey, L.1
Speller, S.2
Gallimore, A.3
Vessey, R.4
-
45
-
-
0027275047
-
Tumor escape from immune response by variation in HLA expression and other mechanisms
-
Bodmer WF, Browning MJ, Krausa P, Rowan A, Bicknell DC and Bodmer JG: Tumor escape from immune response by variation in HLA expression and other mechanisms. Ann N Y Acad Sci 690:42-49, 1993.
-
(1993)
Ann N Y Acad Sci
, vol.690
, pp. 42-49
-
-
Bodmer, W.F.1
Browning, M.J.2
Krausa, P.3
Rowan, A.4
Bicknell, D.C.5
Bodmer, J.G.6
-
46
-
-
0029670776
-
Loss of functional beta 2-microglobulin in metastatic melanomas from five patients receiving immunotherapy
-
Restifo NP, Marincola FM, Kawakami Y, Taubenberger J, Yannelli JR and Rosenberg SA: Loss of functional beta 2-microglobulin in metastatic melanomas from five patients receiving immunotherapy. J Natl Cancer Inst 88:100-108, 1996.
-
(1996)
J Natl Cancer Inst
, vol.88
, pp. 100-108
-
-
Restifo, N.P.1
Marincola, F.M.2
Kawakami, Y.3
Taubenberger, J.4
Yannelli, J.R.5
Rosenberg, S.A.6
-
48
-
-
0032520053
-
HLA class I antigen and transporter associated with antigen processing (TAP1 and TAP2) downregulation in high-grade primary breast carcinoma lesions
-
Vitale M, Rezzani R, Rodella L, Zauli G, Grigolato P, Cadei M, Hicklin DJ and Ferrone S: HLA class I antigen and transporter associated with antigen processing (TAP1 and TAP2) downregulation in high-grade primary breast carcinoma lesions. Cancer Res 58:737-742, 1998.
-
(1998)
Cancer Res
, vol.58
, pp. 737-742
-
-
Vitale, M.1
Rezzani, R.2
Rodella, L.3
Zauli, G.4
Grigolato, P.5
Cadei, M.6
Hicklin, D.J.7
Ferrone, S.8
-
49
-
-
0034053497
-
Sensitization of tumour cells to lysis by virus-specific CTL using antibody-targeted MHC class I/peptide complexes
-
Ogg GS, Dunbar PR, Cerundolo V, McMichael AJ, Lemoine NR and Savage P: Sensitization of tumour cells to lysis by virus-specific CTL using antibody-targeted MHC class I/peptide complexes. Br J Cancer 82:1058-1062, 2000.
-
(2000)
Br J Cancer
, vol.82
, pp. 1058-1062
-
-
Ogg, G.S.1
Dunbar, P.R.2
Cerundolo, V.3
McMichael, A.J.4
Lemoine, N.R.5
Savage, P.6
-
50
-
-
0033747396
-
Antibody-conjugated MHC class I tetramers can target tumor cells for specific lysis by T lymphocytes
-
Robert B, Guillaume P, Luescher I, Romero P and Mach JP: Antibody-conjugated MHC class I tetramers can target tumor cells for specific lysis by T lymphocytes. Eur J Immunol 30:3165-3170, 2000.
-
(2000)
Eur J Immunol
, vol.30
, pp. 3165-3170
-
-
Robert, B.1
Guillaume, P.2
Luescher, I.3
Romero, P.4
Mach, J.P.5
-
51
-
-
0036533526
-
Anti-viral cytotoxic T cells inhibit the growth of cancer cells with antibody targeted HLA class I/peptide complexes in SCID mice
-
Savage P, Cowburn P, Clayton A, Man S, Lawson T, Ogg G, Lemoine N, McMichael A and Epenetos A: Anti-viral cytotoxic T cells inhibit the growth of cancer cells with antibody targeted HLA class I/peptide complexes in SCID mice. Int J Cancer 98:561-566, 2002.
-
(2002)
Int J Cancer
, vol.98
, pp. 561-566
-
-
Savage, P.1
Cowburn, P.2
Clayton, A.3
Man, S.4
Lawson, T.5
Ogg, G.6
Lemoine, N.7
McMichael, A.8
Epenetos, A.9
-
52
-
-
3142582516
-
Redirecting anti-viral CTL against cancer cells by surface targeting of monomeric MHC class I-viral peptide conjugated to antibody fragments
-
Robert B, Guillaume P, Luescher I, Doucey MA, Cerottini JC, Romero P and Mach JP: Redirecting anti-viral CTL against cancer cells by surface targeting of monomeric MHC class I-viral peptide conjugated to antibody fragments. Cancer Immun 1:2, 2001.
-
(2001)
Cancer Immun
, vol.1
, pp. 2
-
-
Robert, B.1
Guillaume, P.2
Luescher, I.3
Doucey, M.A.4
Cerottini, J.C.5
Romero, P.6
Mach, J.P.7
-
53
-
-
3042743864
-
In vivo targeting of an anti-tumor antibody coupled to antigenic MHC class I complexes induces specific growth inhibition and regression of established syngeneic tumor grafts
-
Donda A, Cesson V, Mach JP, Corradin G, Primus FJ and Robert B: In vivo targeting of an anti-tumor antibody coupled to antigenic MHC class I complexes induces specific growth inhibition and regression of established syngeneic tumor grafts. Cancer Immunity 3:11, 2003
-
(2003)
Cancer Immunity
, vol.3
, pp. 11
-
-
Donda, A.1
Cesson, V.2
Mach, J.P.3
Corradin, G.4
Primus, F.J.5
Robert, B.6
-
54
-
-
34249693089
-
Novel antibodies as anticancer agents
-
Zafir-Lavie I, Michaeli Y and Reiter Y: Novel antibodies as anticancer agents. Oncogene 26:3714-3733, 2007.
-
(2007)
Oncogene
, vol.26
, pp. 3714-3733
-
-
Zafir-Lavie, I.1
Michaeli, Y.2
Reiter, Y.3
-
55
-
-
0037105621
-
Recruitment of CTL activity by tumor-specific antibody-mediated targeting of single-chain class I MHC-peptide complexes
-
Lev A, Novak H, Segal D and Reiter Y: Recruitment of CTL activity by tumor-specific antibody-mediated targeting of single-chain class I MHC-peptide complexes. J Immunol 169:2988-2996, 2002.
-
(2002)
J Immunol
, vol.169
, pp. 2988-2996
-
-
Lev, A.1
Novak, H.2
Segal, D.3
Reiter, Y.4
-
56
-
-
22244440749
-
Antibodymediated targeting of human single-chain class I MHC with covalently linked peptides induces efficient killing of tumor cells by tumor or viral-specific cytotoxic T lymphocytes
-
Oved K, Lev A, Noy R, Segal D and Reiter Y: Antibodymediated targeting of human single-chain class I MHC with covalently linked peptides induces efficient killing of tumor cells by tumor or viral-specific cytotoxic T lymphocytes. Cancer Immunol Immunother 54:867-879, 2005.
-
(2005)
Cancer Immunol Immunother
, vol.54
, pp. 867-879
-
-
Oved, K.1
Lev, A.2
Noy, R.3
Segal, D.4
Reiter, Y.5
-
57
-
-
2942630604
-
Tumor-specific Ab-mediated targeting of MHC-peptide complexes induces regression of human tumor xenografts in vivo
-
Lev A, Noy R, Oved K, Novak H, Segal D, Walden P, Zehn D and Reiter Y: Tumor-specific Ab-mediated targeting of MHC-peptide complexes induces regression of human tumor xenografts in vivo. Proc Natl Acad Sci USA 101:9051-9056, 2004.
-
(2004)
Proc Natl Acad Sci USA
, vol.101
, pp. 9051-9056
-
-
Lev, A.1
Noy, R.2
Oved, K.3
Novak, H.4
Segal, D.5
Walden, P.6
Zehn, D.7
Reiter, Y.8
-
59
-
-
1242329830
-
Epidermal growth factor receptor: A promising target in solid tumors
-
Laskin JJ and Sandler AB: Epidermal growth factor receptor: a promising target in solid tumors. Cancer Treat Rev 30:1-17, 2004.
-
(2004)
Cancer Treat Rev
, vol.30
, pp. 1-17
-
-
Laskin, J.J.1
Sandler, A.B.2
-
60
-
-
3042663513
-
Cetuximab in advanced non-small cell lung cancer
-
Govindan R. Cetuximab in advanced non-small cell lung cancer. Clin Cancer Res 10:4241s-4244s, 2004.
-
(2004)
Clin Cancer Res
, vol.10
, pp. 4241s-4244s
-
-
Govindan, R.1
-
61
-
-
33845625695
-
Selective antibody-mediated targeting of class I MHC to EGFR-expressing tumor cells induces potent antitumor CTL activity in vitro and in vivo
-
Novak H, Noy R, Oved K, Segal D, Wels WS and Reiter Y: Selective antibody-mediated targeting of class I MHC to EGFR-expressing tumor cells induces potent antitumor CTL activity in vitro and in vivo. Int J Cancer 120:329-336, 2007.
-
(2007)
Int J Cancer
, vol.120
, pp. 329-336
-
-
Novak, H.1
Noy, R.2
Oved, K.3
Segal, D.4
Wels, W.S.5
Reiter, Y.6
-
62
-
-
84859068537
-
T cell-receptor-like antibodies - Generation, function and applications
-
Dahan R and Reiter Y: T cell-receptor-like antibodies - generation, function and applications. Expert Rev Mol Med 14:e6, 2012.
-
(2012)
Expert Rev Mol Med
, vol.14
, pp. e6
-
-
Dahan, R.1
Reiter, Y.2
-
63
-
-
79953331837
-
MHC class I-presented lung cancer-associated tumor antigens identified by immunoproteomics analysis are targets for cancer-specific T cell response
-
Shetty V, Sinnathamby G, Nickens Z, Shah P, Hafner J, Mariello L, Kamal S, Vlahovic G, Lyerly HK, Morse MA and Philip R: MHC class I-presented lung cancer-associated tumor antigens identified by immunoproteomics analysis are targets for cancer-specific T cell response. J Proteomics 74:728-743, 2011.
-
(2011)
J Proteomics
, vol.74
, pp. 728-743
-
-
Shetty, V.1
Sinnathamby, G.2
Nickens, Z.3
Shah, P.4
Hafner, J.5
Mariello, L.6
Kamal, S.7
Vlahovic, G.8
Lyerly, H.K.9
Morse, M.A.10
Philip, R.11
-
64
-
-
80855134483
-
TCR-like biomolecules target peptide/MHC Class I complexes on the surface of infected and cancerous cells
-
Weidanz JA, Hawkins O, Verma B and Hildebrand WH: TCR-like biomolecules target peptide/MHC Class I complexes on the surface of infected and cancerous cells. Int Rev Immunol 30:328-340, 2011.
-
(2011)
Int Rev Immunol
, vol.30
, pp. 328-340
-
-
Weidanz, J.A.1
Hawkins, O.2
Verma, B.3
Hildebrand, W.H.4
-
65
-
-
0032948397
-
Recombinant antibodies with the antigen-specific, MHC restricted specificity of T cells: Novel reagents for basic and clinical investigations and immunotherapy
-
Engberg J, Krogsgaard M and Fugger L: Recombinant antibodies with the antigen-specific, MHC restricted specificity of T cells: novel reagents for basic and clinical investigations and immunotherapy. Immunotechnology 4:273-278, 1999.
-
(1999)
Immunotechnology
, vol.4
, pp. 273-278
-
-
Engberg, J.1
Krogsgaard, M.2
Fugger, L.3
-
66
-
-
0030935662
-
Peptide-specific killing of antigen-presenting cells by a recombinant antibody-toxin fusion protein targeted to major histocompatibility complex/peptide class I complexes with T cell receptor-like specificity
-
Reiter Y, Di Carlo A, Fugger L, Engberg J and Pastan I: Peptide-specific killing of antigen-presenting cells by a recombinant antibody-toxin fusion protein targeted to major histocompatibility complex/peptide class I complexes with T cell receptor-like specificity. Proc Natl Acad Sci USA 94:4631-4636, 1997.
-
(1997)
Proc Natl Acad Sci USA
, vol.94
, pp. 4631-4636
-
-
Reiter, Y.1
Di Carlo, A.2
Fugger, L.3
Engberg, J.4
Pastan, I.5
-
67
-
-
0030752446
-
Heterogeneous expression of immunotherapy candidate proteins gp100, MART-1, and tyrosinase in human melanoma cell lines and in human melanocytic lesions
-
de Vries TJ, Fourkour A, Wobbes T, Verkroost G, Ruiter DJ and van Muijen GN: Heterogeneous expression of immunotherapy candidate proteins gp100, MART-1, and tyrosinase in human melanoma cell lines and in human melanocytic lesions. Cancer Res 57:3223-3229, 1997.
-
(1997)
Cancer Res
, vol.57
, pp. 3223-3229
-
-
De Vries, T.J.1
Fourkour, A.2
Wobbes, T.3
Verkroost, G.4
Ruiter, D.J.5
Van Muijen, G.N.6
-
68
-
-
0028303166
-
A new gene coding for a differentiation antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas
-
Coulie PG, Brichard V, Van Pel A, Wölfel T, Schneider J, Traversari C, Mattei S, De Plaen E, Lurquin C, Szikora JP, Renauld JC and Boon T: A new gene coding for a differentiation antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas. J Exp Med 180:35-42, 1994.
-
(1994)
J Exp Med
, vol.180
, pp. 35-42
-
-
Coulie, P.G.1
Brichard, V.2
Van Pel, A.3
Wölfel, T.4
Schneider, J.5
Traversari, C.6
Mattei, S.7
De Plaen, E.8
Lurquin, C.9
Szikora, J.P.10
Renauld, J.C.11
Boon, T.12
-
69
-
-
0028302028
-
Identification of the immunodominant peptides of the MART-1 human melanoma antigen recognized by the majority of HLA-A2-restricted tumor infiltrating lymphocytes
-
Kawakami Y, Eliyahu S, Sakaguchi K, Robbins PF, Rivoltini L, Yannelli JR, Appella E and Rosenberg SA: Identification of the immunodominant peptides of the MART-1 human melanoma antigen recognized by the majority of HLA-A2-restricted tumor infiltrating lymphocytes. J Exp Med 180:347-352, 1994.
-
(1994)
J Exp Med
, vol.180
, pp. 347-352
-
-
Kawakami, Y.1
Eliyahu, S.2
Sakaguchi, K.3
Robbins, P.F.4
Rivoltini, L.5
Yannelli, J.R.6
Appella, E.7
Rosenberg, S.A.8
-
70
-
-
12144286633
-
NY-ESO-1 expression and immunogenicity in malignant and benign breast tumors
-
Sugita Y, Wada H, Fujita S, Nakata T, Sato S, Noguchi Y, Jungbluth AA, Yamaguchi M, Chen YT, Stockert E, Gnjatic S, Williamson B, Scanlan MJ, Ono T, Sakita I, Yasui M, Miyoshi Y, Tamaki Y, Matsuura N, Noguchi S, Old LJ, Nakayama E and Monden M: NY-ESO-1 expression and immunogenicity in malignant and benign breast tumors. Cancer Res 64:2199-2204, 2004.
-
(2004)
Cancer Res
, vol.64
, pp. 2199-2204
-
-
Sugita, Y.1
Wada, H.2
Fujita, S.3
Nakata, T.4
Sato, S.5
Noguchi, Y.6
Jungbluth, A.A.7
Yamaguchi, M.8
Chen, Y.T.9
Stockert, E.10
Gnjatic, S.11
Williamson, B.12
Scanlan, M.J.13
Ono, T.14
Sakita, I.15
Yasui, M.16
Miyoshi, Y.17
Tamaki, Y.18
Matsuura, N.19
Noguchi, S.20
Old, L.J.21
Nakayama, E.22
Monden, M.23
more..
-
71
-
-
3042687137
-
NY-ESO-1 mRNA expression and immunogenicity in advanced prostate cancer
-
Nakada T, Noguchi Y, Satoh S, Ono T, Saika T, Kurashige T, Gnjatic S, Ritter G, Chen YT, Stockert E, Nasu Y, Tsushima T, Kumon H, Old LJ and Nakayama E: NY-ESO-1 mRNA expression and immunogenicity in advanced prostate cancer. Cancer Immun 3:10, 2003.
-
(2003)
Cancer Immun
, vol.3
, pp. 10
-
-
Nakada, T.1
Noguchi, Y.2
Satoh, S.3
Ono, T.4
Saika, T.5
Kurashige, T.6
Gnjatic, S.7
Ritter, G.8
Chen, Y.T.9
Stockert, E.10
Nasu, Y.11
Tsushima, T.12
Kumon, H.13
Old, L.J.14
Nakayama, E.15
-
72
-
-
84890281763
-
Companion biomarkers: Paving the pathway to personalized treatment for cancer
-
Duffy MJ and Crown J: Companion biomarkers: paving the pathway to personalized treatment for cancer. Clin Chem 59:1447-1456, 2013.
-
(2013)
Clin Chem
, vol.59
, pp. 1447-1456
-
-
Duffy, M.J.1
Crown, J.2
-
73
-
-
0030949463
-
Activation of beta-catenin-Tcf signaling in colon cancer by mutations in beta-catenin or APC
-
Morin PJ, Sparks AB, Korinek V, Barker N, Clevers H, Vogelstein B and Kinzler KW: Activation of beta-catenin-Tcf signaling in colon cancer by mutations in beta-catenin or APC. Science 275:1787-1790, 1997.
-
(1997)
Science
, vol.275
, pp. 1787-1790
-
-
Morin, P.J.1
Sparks, A.B.2
Korinek, V.3
Barker, N.4
Clevers, H.5
Vogelstein, B.6
Kinzler, K.W.7
-
74
-
-
0021688634
-
The neu oncogene: An erb-B-related gene encoding a 185, 000-Mr tumor antigen
-
Schechter AL, Stern DF, Vaidyanathan L, Decker SJ, Drebin JA, Greene MI and Weinberg RA: The neu oncogene: an erb-B-related gene encoding a 185, 000-Mr tumor antigen. Nature 312:513-516, 1984.
-
(1984)
Nature
, vol.312
, pp. 513-516
-
-
Schechter, A.L.1
Stern, D.F.2
Vaidyanathan, L.3
Decker, S.J.4
Drebin, J.A.5
Greene, M.I.6
Weinberg, R.A.7
-
75
-
-
0022406444
-
Amplification of a novel v-erbB-related gene in a human mammary carcinoma
-
King CR, Kraus MH and Aaronson SA: Amplification of a novel v-erbB-related gene in a human mammary carcinoma. Science 229:974-976, 1985.
-
(1985)
Science
, vol.229
, pp. 974-976
-
-
King, C.R.1
Kraus, M.H.2
Aaronson, S.A.3
-
76
-
-
80755188010
-
Expanding the targets available to therapeutic antibodies via novel disease-specific markers
-
Weidanz JA and Hildebrand WH: Expanding the targets available to therapeutic antibodies via novel disease-specific markers. Int Rev Immunol 30:312-327, 2011.
-
(2011)
Int Rev Immunol
, vol.30
, pp. 312-327
-
-
Weidanz, J.A.1
Hildebrand, W.H.2
-
77
-
-
45549083537
-
∗0201
-
∗0201. J Proteome Res 7:1445-1457, 2008.
-
(2008)
J Proteome Res
, vol.7
, pp. 1445-1457
-
-
Hawkins, O.E.1
Vangundy, R.S.2
Eckerd, A.M.3
Bardet, W.4
Buchli, R.5
Weidanz, J.A.6
Hildebrand, W.H.7
-
78
-
-
0034535585
-
Recombinant human single-chain MHC-peptide complexes made from E coli by in vitro refolding: Functional single-chain MHC-peptide complexes and tetramers with tumor associated antigens
-
Denkberg G, Cohen CJ, Segal D, Kirkin AF and Reiter Y: Recombinant human single-chain MHC-peptide complexes made from E. coli by in vitro refolding: functional single-chain MHC-peptide complexes and tetramers with tumor associated antigens. Eur J Immunol 30:3522-3532, 2000.
-
(2000)
Eur J Immunol
, vol.30
, pp. 3522-3532
-
-
Denkberg, G.1
Cohen, C.J.2
Segal, D.3
Kirkin, A.F.4
Reiter, Y.5
-
79
-
-
0026529908
-
HLA-A2-peptide complexes: Refolding and crystallization of molecules expressed in Escherichia coli and complexed with single antigenic peptides
-
Garboczi DN, Hung DT and Wiley DC: HLA-A2-peptide complexes: refolding and crystallization of molecules expressed in Escherichia coli and complexed with single antigenic peptides. Proc Natl Acad Sci USA 89:3429-3433, 1992.
-
(1992)
Proc Natl Acad Sci USA
, vol.89
, pp. 3429-3433
-
-
Garboczi, D.N.1
Hung, D.T.2
Wiley, D.C.3
-
80
-
-
0029814159
-
Shared fine specificity between T cell receptors and an antibody recognizing a peptide/major histocompatibility class I complex
-
Stryhn A, Andersen PS, Pedersen LO, Svejgaard A, Holm A, Thorpe CJ, Fugger L, Buus S and Engberg J: Shared fine specificity between T cell receptors and an antibody recognizing a peptide/major histocompatibility class I complex. Proc Natl Acad Sci USA 93:10338-10342, 1996.
-
(1996)
Proc Natl Acad Sci USA
, vol.93
, pp. 10338-10342
-
-
Stryhn, A.1
Andersen, P.S.2
Pedersen, L.O.3
Svejgaard, A.4
Holm, A.5
Thorpe, C.J.6
Fugger, L.7
Buus, S.8
Engberg, J.9
-
81
-
-
27144431943
-
Selecting and screening recombinant antibody libraries
-
Hoogenboom HR: Selecting and screening recombinant antibody libraries. Nat Biotechnol 23:1105-1116, 2005.
-
(2005)
Nat Biotechnol
, vol.23
, pp. 1105-1116
-
-
Hoogenboom, H.R.1
-
82
-
-
0033603596
-
A large non-immunized human Fab fragment phage library that permits rapid isolation and kinetic analysis of high affinity antibodies
-
de Haard HJ, van Neer N, Reurs A, Hufton SE, Roovers RC, Henderikx P, de Bruïne AP, Arends JW and Hoogenboom HR: A large non-immunized human Fab fragment phage library that permits rapid isolation and kinetic analysis of high affinity antibodies. J Biol Chem 274:18218-18230, 1999.
-
(1999)
J Biol Chem
, vol.274
, pp. 18218-18230
-
-
De Haard, H.J.1
Van Neer, N.2
Reurs, A.3
Hufton, S.E.4
Roovers, R.C.5
Henderikx, P.6
De Bruïne, A.P.7
Arends, J.W.8
Hoogenboom, H.R.9
-
83
-
-
0028291823
-
Isolation of high affinity human antibodies directly from large synthetic repertoires
-
Griffiths AD, Williams SC, Hartley O, Tomlinson IM, Waterhouse P, Crosby WL, Kontermann RE, Jones PT, Low NM and Allison TJ: Isolation of high affinity human antibodies directly from large synthetic repertoires. EMBO J 13:3245-3260, 1994.
-
(1994)
EMBO J
, vol.13
, pp. 3245-3260
-
-
Griffiths, A.D.1
Williams, S.C.2
Hartley, O.3
Tomlinson, I.M.4
Waterhouse, P.5
Crosby, W.L.6
Kontermann, R.E.7
Jones, P.T.8
Low, N.M.9
Allison, T.J.10
-
84
-
-
0034678450
-
Visualization of myelin basic protein (MBP) T cell epitopes in multiple sclerosis lesions using a monoclonal antibody specific for the human histocompatibility leukocyte antigen (HLA)-DR2-MBP 85-99 complex
-
Krogsgaard M, Wucherpfennig KW, Cannella B, Hansen BE, Svejgaard A, Pyrdol J, Ditzel H, Raine C, Engberg J and Fugger L: Visualization of myelin basic protein (MBP) T cell epitopes in multiple sclerosis lesions using a monoclonal antibody specific for the human histocompatibility leukocyte antigen (HLA)-DR2-MBP 85-99 complex. J Exp Med 191:1395-1412, 2000.
-
(2000)
J Exp Med
, vol.191
, pp. 1395-1412
-
-
Krogsgaard, M.1
Wucherpfennig, K.W.2
Cannella, B.3
Hansen, B.E.4
Svejgaard, A.5
Pyrdol, J.6
Ditzel, H.7
Raine, C.8
Engberg, J.9
Fugger, L.10
-
85
-
-
0041428152
-
Selective targeting of melanoma and APCs using a recombinant antibody with TCR-like specificity directed toward a melanoma differentiation antigen
-
Denkberg G, Lev A, Eisenbach L, Benhar I and Reiter Y: Selective targeting of melanoma and APCs using a recombinant antibody with TCR-like specificity directed toward a melanoma differentiation antigen. J Immunol 171:2197-2207, 2003.
-
(2003)
J Immunol
, vol.171
, pp. 2197-2207
-
-
Denkberg, G.1
Lev, A.2
Eisenbach, L.3
Benhar, I.4
Reiter, Y.5
-
86
-
-
0030745938
-
Characterization and quantitation of peptide-MHC complexes produced from hen egg lysozyme using a monoclonal antibody
-
Dadaglio G, Nelson CA, Deck MB, Petzold SJ and Unanue ER: Characterization and quantitation of peptide-MHC complexes produced from hen egg lysozyme using a monoclonal antibody. Immunity 6:727-738, 1997.
-
(1997)
Immunity
, vol.6
, pp. 727-738
-
-
Dadaglio, G.1
Nelson, C.A.2
Deck, M.B.3
Petzold, S.J.4
Unanue, E.R.5
-
87
-
-
0030849769
-
Localization, quantitation, and in situ detection of specific peptide-MHC class I complexes using a monoclonal antibody
-
Porgador A, Yewdell JW, Deng Y, Bennink JR and Germain RN: Localization, quantitation, and in situ detection of specific peptide-MHC class I complexes using a monoclonal antibody. Immunity 6:715-726, 1997.
-
(1997)
Immunity
, vol.6
, pp. 715-726
-
-
Porgador, A.1
Yewdell, J.W.2
Deng, Y.3
Bennink, J.R.4
Germain, R.N.5
-
88
-
-
79955966609
-
An anti-PR1/HLA-A2 T cell receptor-like antibody mediates complement-dependent cytotoxicity against acute myeloid leukemia progenitor cells
-
Sergeeva A, Alatrash G, He H, Ruisaard K, Lu S, Wygant J, McIntyre BW, Ma Q, Li D, St John L, Clise-Dwyer K and Molldrem JJ: An anti-PR1/HLA-A2 T cell receptor-like antibody mediates complement-dependent cytotoxicity against acute myeloid leukemia progenitor cells. Blood 117:4262-4272, 2011.
-
(2011)
Blood
, vol.117
, pp. 4262-4272
-
-
Sergeeva, A.1
Alatrash, G.2
He, H.3
Ruisaard, K.4
Lu, S.5
Wygant, J.6
McIntyre, B.W.7
Ma, Q.8
Li, D.9
John, L.S.10
Clise-Dwyer, K.11
Molldrem, J.J.12
-
89
-
-
33748492327
-
Antibody targeting to a class I MHC-peptide epitope promotes tumor cell death
-
Wittman VP, Woodburn D, Nguyen T, Neethling FA, Wright S and Weidanz JA: Antibody targeting to a class I MHC-peptide epitope promotes tumor cell death. J Immunol 177:4187-4195, 2006.
-
(2006)
J Immunol
, vol.177
, pp. 4187-4195
-
-
Wittman, V.P.1
Woodburn, D.2
Nguyen, T.3
Neethling, F.A.4
Wright, S.5
Weidanz, J.A.6
-
90
-
-
79551697736
-
Targeting hepatitis B virus-infected cells with a T cell receptor-like antibody
-
Sastry KS, Too CT, Kaur K, Gehring AJ, Low L, Javiad A, Pollicino T, Li L, Kennedy PT, Lopatin U, Macary PA and Bertoletti A: Targeting hepatitis B virus-infected cells with a T cell receptor-like antibody. J Virol 85:1935-1942, 2011.
-
(2011)
J Virol
, vol.85
, pp. 1935-1942
-
-
Sastry, K.S.1
Too, C.T.2
Kaur, K.3
Gehring, A.J.4
Low, L.5
Javiad, A.6
Pollicino, T.7
Li, L.8
Kennedy, P.T.9
Lopatin, U.10
Macary, P.A.11
Bertoletti, A.12
-
91
-
-
0037108683
-
Direct detection and quantitation of a distinct T cell epitope derived from tumor-specific epithelial cell-associated mucin using human recombinant antibodies endowed with the antigen-specific, major histocompatibility complex-restricted specificity of T cells
-
Cohen CJ, Hoffmann N, Farago M, Hoogenboom HR, Eisenbach L and Reiter Y: Direct detection and quantitation of a distinct T cell epitope derived from tumor-specific epithelial cell-associated mucin using human recombinant antibodies endowed with the antigen-specific, major histocompatibility complex-restricted specificity of T cells. Cancer Res 62:5835-5844, 2002.
-
(2002)
Cancer Res
, vol.62
, pp. 5835-5844
-
-
Cohen, C.J.1
Hoffmann, N.2
Farago, M.3
Hoogenboom, H.R.4
Eisenbach, L.5
Reiter, Y.6
-
92
-
-
0012054787
-
Generation of recombinant immunotoxins for specific targeting of tumorrelated peptides presented by MHC molecules
-
Cohen CJ, Denkberg G, Segal D and Reiter Y: Generation of recombinant immunotoxins for specific targeting of tumorrelated peptides presented by MHC molecules. Methods Mol Biol 207:269-282, 2003.
-
(2003)
Methods Mol Biol
, vol.207
, pp. 269-282
-
-
Cohen, C.J.1
Denkberg, G.2
Segal, D.3
Reiter, Y.4
-
93
-
-
51049104493
-
Antitumor activity of immunotoxins with T cell receptor-like specificity against human melanoma xenografts
-
Klechevsky E, Gallegos M, Denkberg G, Palucka K, Banchereau J, Cohen C and Reiter Y: Antitumor activity of immunotoxins with T cell receptor-like specificity against human melanoma xenografts. Cancer Res 68:6360-6367, 2008.
-
(2008)
Cancer Res
, vol.68
, pp. 6360-6367
-
-
Klechevsky, E.1
Gallegos, M.2
Denkberg, G.3
Palucka, K.4
Banchereau, J.5
Cohen, C.6
Reiter, Y.7
-
94
-
-
49649129991
-
Targeting TARP, a novel breast and prostate tumor-associated antigen, with T cell receptor-like human recombinant antibodies
-
Epel M, Carmi I, Soueid-Baumgarten S, Oh SK, Bera T, Pastan I, Berzofsky J and Reiter Y: Targeting TARP, a novel breast and prostate tumor-associated antigen, with T cell receptor-like human recombinant antibodies. Eur J Immunol 38:1706-1720, 2008.
-
(2008)
Eur J Immunol
, vol.38
, pp. 1706-1720
-
-
Epel, M.1
Carmi, I.2
Soueid-Baumgarten, S.3
Oh, S.K.4
Bera, T.5
Pastan, I.6
Berzofsky, J.7
Reiter, Y.8
-
95
-
-
77949895698
-
TCR mimic monoclonal antibody targets a specific peptide/HLA class I complex and significantly impedes tumor growth in vivo using breast cancer models
-
Verma B, Neethling FA, Caseltine S, Fabrizio G, Largo S, Duty JA, Tabaczewski P and Weidanz JA: TCR mimic monoclonal antibody targets a specific peptide/HLA class I complex and significantly impedes tumor growth in vivo using breast cancer models. J Immunol 184:2156-2165, 2010.
-
(2010)
J Immunol
, vol.184
, pp. 2156-2165
-
-
Verma, B.1
Neethling, F.A.2
Caseltine, S.3
Fabrizio, G.4
Largo, S.5
Duty, J.A.6
Tabaczewski, P.7
Weidanz, J.A.8
-
96
-
-
79952748078
-
TCR mimic monoclonal antibodies induce apoptosis of tumor cells via immune effector-independent mechanisms
-
Verma B, Jain R, Caseltine S, Rennels A, Bhattacharya R, Markiewski MM, Rawat A, Neethling F, Bickel U and Weidanz JA: TCR mimic monoclonal antibodies induce apoptosis of tumor cells via immune effector-independent mechanisms. J Immunol 186:3265-3276, 2011.
-
(2011)
J Immunol
, vol.186
, pp. 3265-3276
-
-
Verma, B.1
Jain, R.2
Caseltine, S.3
Rennels, A.4
Bhattacharya, R.5
Markiewski, M.M.6
Rawat, A.7
Neethling, F.8
Bickel, U.9
Weidanz, J.A.10
-
97
-
-
79958025265
-
An HLA-presented fragment of macrophage migration inhibitory factor is a therapeutic target for invasive breast cancer
-
Hawkins O, Verma B, Lightfoot S, Jain R, Rawat A, McNair S, Caseltine S, Mojsilovic A, Gupta P, Neethling F, Almanza O, Dooley W, Hildebrand W and Weidanz J: An HLA-presented fragment of macrophage migration inhibitory factor is a therapeutic target for invasive breast cancer. J Immunol 186:6607-6616, 2011.
-
(2011)
J Immunol
, vol.186
, pp. 6607-6616
-
-
Hawkins, O.1
Verma, B.2
Lightfoot, S.3
Jain, R.4
Rawat, A.5
McNair, S.6
Caseltine, S.7
Mojsilovic, A.8
Gupta, P.9
Neethling, F.10
Almanza, O.11
Dooley, W.12
Hildebrand, W.13
Weidanz, J.14
-
98
-
-
84873587154
-
Antitumor activity of a monoclonal antibody targeting major histocompatibility complex class I-Her2 peptide complexes
-
Jain R, Rawat A, Verma B, Markiewski MM and Weidanz JA: Antitumor activity of a monoclonal antibody targeting major histocompatibility complex class I-Her2 peptide complexes. J Natl Cancer Inst 105:202-218, 2013.
-
(2013)
J Natl Cancer Inst
, vol.105
, pp. 202-218
-
-
Jain, R.1
Rawat, A.2
Verma, B.3
Markiewski, M.M.4
Weidanz, J.A.5
-
99
-
-
79960299888
-
Durable complete responses in heavily pretreated patients with metastatic melanoma using T cell transfer immunotherapy
-
Rosenberg SA, Yang JC, Sherry RM, Kammula US, Hughes MS, Phan GQ, Citrin DE, Restifo NP, Robbins PF, Wunderlich JR, Morton KE, Laurencot CM, Steinberg SM, White DE and Dudley ME: Durable complete responses in heavily pretreated patients with metastatic melanoma using T cell transfer immunotherapy. Clin Cancer Res 17:4550-4557, 2011.
-
(2011)
Clin Cancer Res
, vol.17
, pp. 4550-4557
-
-
Rosenberg, S.A.1
Yang, J.C.2
Sherry, R.M.3
Kammula, U.S.4
Hughes, M.S.5
Phan, G.Q.6
Citrin, D.E.7
Restifo, N.P.8
Robbins, P.F.9
Wunderlich, J.R.10
Morton, K.E.11
Laurencot, C.M.12
Steinberg, S.M.13
White, D.E.14
Dudley, M.E.15
-
101
-
-
55949125601
-
Adoptive cell therapy for patients with metastatic melanoma: Evaluation of intensive myeloablative chemoradiation preparative regimens
-
Dudley ME, Yang JC, Sherry R, Hughes MS, Royal R, Kammula U, Robbins PF, Huang J, Citrin DE, Leitman SF, Wunderlich J, Restifo NP, Thomasian A, Downey SG, Smith FO, Klapper J, Morton K, Laurencot C, White DE and Rosenberg SA: Adoptive cell therapy for patients with metastatic melanoma: evaluation of intensive myeloablative chemoradiation preparative regimens. J Clin Oncol 26:5233-5239, 2008.
-
(2008)
J Clin Oncol
, vol.26
, pp. 5233-5239
-
-
Dudley, M.E.1
Yang, J.C.2
Sherry, R.3
Hughes, M.S.4
Royal, R.5
Kammula, U.6
Robbins, P.F.7
Huang, J.8
Citrin, D.E.9
Leitman, S.F.10
Wunderlich, J.11
Restifo, N.P.12
Thomasian, A.13
Downey, S.G.14
Smith, F.O.15
Klapper, J.16
Morton, K.17
Laurencot, C.18
White, D.E.19
Rosenberg, S.A.20
more..
-
102
-
-
84877141205
-
Engineering T cell function using chimeric antigen receptors identified using a DNA library approach
-
Duong CP, Westwood JA, Yong CS, Murphy A, Devaud C, John LB, Darcy PK and Kershaw MH: Engineering T cell function using chimeric antigen receptors identified using a DNA library approach. PLoS One 8:e63037, 2013.
-
(2013)
PLoS One
, vol.8
, pp. e63037
-
-
Duong, C.P.1
Westwood, J.A.2
Yong, C.S.3
Murphy, A.4
Devaud, C.5
John, L.B.6
Darcy, P.K.7
Kershaw, M.H.8
-
103
-
-
77950961198
-
Building better chimeric antigen receptors for adoptive T cell therapy
-
Bridgeman JS, Hawkins RE, Hombach AA, Abken H and Gilham DE: Building better chimeric antigen receptors for adoptive T cell therapy. Curr Gene Ther 10:77-90, 2010.
-
(2010)
Curr Gene Ther
, vol.10
, pp. 77-90
-
-
Bridgeman, J.S.1
Hawkins, R.E.2
Hombach, A.A.3
Abken, H.4
Gilham, D.E.5
-
104
-
-
84890179288
-
Of CARs and TRUCKs: Chimeric antigen receptor (CAR) T cells engineered with an inducible cytokine to modulate the tumor stroma
-
Chmielewski M, Hombach AA and Abken H: Of CARs and TRUCKs: chimeric antigen receptor (CAR) T cells engineered with an inducible cytokine to modulate the tumor stroma. Immunol Rev 257:83-90, 2014.
-
(2014)
Immunol Rev
, vol.257
, pp. 83-90
-
-
Chmielewski, M.1
Hombach, A.A.2
Abken, H.3
-
105
-
-
84858759305
-
Tumor-targeted T cells modified to secrete IL-12 eradicate systemic tumors without need for prior conditioning
-
Pegram HJ, Lee JC, Hayman EG, Imperato GH, Tedder TF, Sadelain M and Brentjens RJ: Tumor-targeted T cells modified to secrete IL-12 eradicate systemic tumors without need for prior conditioning. Blood 119:4133-4141, 2012.
-
(2012)
Blood
, vol.119
, pp. 4133-4141
-
-
Pegram, H.J.1
Lee, J.C.2
Hayman, E.G.3
Imperato, G.H.4
Tedder, T.F.5
Sadelain, M.6
Brentjens, R.J.7
-
106
-
-
77956280888
-
Tumor-specific CD8+ T cells expressing interleukin-12 eradicate established cancers in lymphodepleted hosts
-
Kerkar S P, Muranski P, Kaiser A, Boni A, Sanchez-Perez L, Yu Z, Palmer DC, Reger RN, Borman ZA, Zhang L, Morgan RA, Gattinoni L, Rosenberg SA, Trinchieri G and Restifo NP: Tumor-specific CD8+ T cells expressing interleukin-12 eradicate established cancers in lymphodepleted hosts. Cancer Res 70:6725-6734, 2010.
-
(2010)
Cancer Res
, vol.70
, pp. 6725-6734
-
-
Kerkar, S.P.1
Muranski, P.2
Kaiser, A.3
Boni, A.4
Sanchez-Perez, L.5
Yu, Z.6
Palmer, D.C.7
Reger, R.N.8
Borman, Z.A.9
Zhang, L.10
Morgan, R.A.11
Gattinoni, L.12
Rosenberg, S.A.13
Trinchieri, G.14
Restifo, N.P.15
-
107
-
-
84055217292
-
IL-12 triggers a programmatic change in dysfunctional myeloid-derived cells within mouse tumors
-
Kerkar SP, Goldszmid RS, Muranski P, Chinnasamy D, Yu Z, Reger RN, Leonardi AJ, Morgan RA, Wang E, Marincola FM, Trinchieri G, Rosenberg SA and Restifo NP: IL-12 triggers a programmatic change in dysfunctional myeloid-derived cells within mouse tumors. J Clin Invest 121:4746-4757, 2011.
-
(2011)
J Clin Invest
, vol.121
, pp. 4746-4757
-
-
Kerkar, S.P.1
Goldszmid, R.S.2
Muranski, P.3
Chinnasamy, D.4
Yu, Z.5
Reger, R.N.6
Leonardi, A.J.7
Morgan, R.A.8
Wang, E.9
Marincola, F.M.10
Trinchieri, G.11
Rosenberg, S.A.12
Restifo, N.P.13
-
108
-
-
0038516286
-
The choices of a natural killer
-
Trinchieri G: The choices of a natural killer. Nat Immunol 4:509-510, 2003.
-
(2003)
Nat Immunol
, vol.4
, pp. 509-510
-
-
Trinchieri, G.1
-
109
-
-
67349218153
-
IL-12 delivered intratumorally by multilamellar liposomes reactivates memory T cells in human tumor microenvironments
-
Simpson-Abelson MR, Purohit VS, Pang WM, Iyer V, Odunsi K, Demmy TL, Yokota SJ, Loyall JL, Kelleher RJ Jr, Balu-Iyer S and Bankert RB: IL-12 delivered intratumorally by multilamellar liposomes reactivates memory T cells in human tumor microenvironments. Clin Immunol 132:71-82, 2009.
-
(2009)
Clin Immunol
, vol.132
, pp. 71-82
-
-
Simpson-Abelson, M.R.1
Purohit, V.S.2
Pang, W.M.3
Iyer, V.4
Odunsi, K.5
Demmy, T.L.6
Yokota, S.J.7
Loyall, J.L.8
Kelleher, R.J.9
Balu-Iyer, S.10
Bankert, R.B.11
-
110
-
-
13844262749
-
Intratumoral injection of DNA encoding human interleukin 12 into patients with metastatic melanoma: Clinical efficacy
-
Heinzerling L, Burg G, Dummer R, Maier T, Oberholzer PA, Schultz J, Elzaouk L, Pavlovic J and Moelling K: Intratumoral injection of DNA encoding human interleukin 12 into patients with metastatic melanoma: clinical efficacy. Hum Gene Ther 16:35-48, 2005.
-
(2005)
Hum Gene Ther
, vol.16
, pp. 35-48
-
-
Heinzerling, L.1
Burg, G.2
Dummer, R.3
Maier, T.4
Oberholzer, P.A.5
Schultz, J.6
Elzaouk, L.7
Pavlovic, J.8
Moelling, K.9
-
111
-
-
0035831628
-
Interleukin 12 gene therapy of cancer by peritumoral injection of transduced autologous fibroblasts: Outcome of a phase I study
-
Kang WK, Park C, Yoon HL, Kim WS, Yoon SS, Lee MH, Park K, Kim K, Jeong HS, Kim JA, Nam SJ, Yang JH, Son YI, Baek CH, Han J, Ree HJ, Lee ES, Kim SH, Kim DW, Ahn YC, Huh SJ, Choe YH, Lee JH, Park MH, Kong GS, Park EY, Kang YK, Bang YJ, Paik NS, Lee SN, Kim SH, Kim S, Robbins PD, Tahara H, Lotze MT and Park CH: Interleukin 12 gene therapy of cancer by peritumoral injection of transduced autologous fibroblasts: outcome of a phase I study. Hum Gene Ther 12:671-684, 2001.
-
(2001)
Hum Gene Ther
, vol.12
, pp. 671-684
-
-
Kang, W.K.1
Park, C.2
Yoon, H.L.3
Kim, W.S.4
Yoon, S.S.5
Lee, M.H.6
Park, K.7
Kim, K.8
Jeong, H.S.9
Kim, J.A.10
Nam, S.J.11
Yang, J.H.12
Son, Y.I.13
Baek, C.H.14
Han, J.15
Ree, H.J.16
Lee, E.S.17
Kim, S.H.18
Kim, D.W.19
Ahn, Y.C.20
Huh, S.J.21
Choe, Y.H.22
Lee, J.H.23
Park, M.H.24
Kong, G.S.25
Park, E.Y.26
Kang, Y.K.27
Bang, Y.J.28
Paik, N.S.29
Lee, S.N.30
Kim, S.H.31
Kim, S.32
Robbins, P.D.33
Tahara, H.34
Lotze, M.T.35
Park, C.H.36
more..
-
112
-
-
84877575144
-
Treating B-cell cancer with T cells expressing anti-CD19 chimeric antigen receptors
-
Kochenderfer JN and Rosenberg SA: Treating B-cell cancer with T cells expressing anti-CD19 chimeric antigen receptors. Nat Rev Clin Oncol 10:267-276, 2013.
-
(2013)
Nat Rev Clin Oncol
, vol.10
, pp. 267-276
-
-
Kochenderfer, J.N.1
Rosenberg, S.A.2
-
115
-
-
84868573518
-
Genetic modification of human T lymphocytes for the treatment of hematologic malignancies
-
Hoyos V, Savoldo B and Dotti G: Genetic modification of human T lymphocytes for the treatment of hematologic malignancies. Haematologica 97:1622-1631, 2012.
-
(2012)
Haematologica
, vol.97
, pp. 1622-1631
-
-
Hoyos, V.1
Savoldo, B.2
Dotti, G.3
-
116
-
-
84899656300
-
Chimeric antigen receptors for the adoptive T cell therapy of hematologic malignancies
-
Davila ML, Bouhassira DC, Park JH, Curran KJ, Smith EL, Pegram HJ and Brentjens R: Chimeric antigen receptors for the adoptive T cell therapy of hematologic malignancies. Int J Hematol 99:361-371, 2014
-
(2014)
Int J Hematol
, vol.99
, pp. 361-371
-
-
Davila, M.L.1
Bouhassira, D.C.2
Park, J.H.3
Curran, K.J.4
Smith, E.L.5
Pegram, H.J.6
Brentjens, R.7
-
117
-
-
84863337890
-
B-cell depletion and remissions of malignancy along with cytokineassociated toxicity in a clinical trial of anti-CD19 chimericantigen-receptor-transduced T cells
-
Kochenderfer JN, Dudley ME, Feldman SA, Wilson WH, Spaner DE, Maric I, Stetler-Stevenson M, Phan GQ, Hughes MS, Sherry RM, Yang JC, Kammula US, Devillier L, Carpenter R, Nathan DA, Morgan RA, Laurencot C and Rosenberg SA: B-cell depletion and remissions of malignancy along with cytokineassociated toxicity in a clinical trial of anti-CD19 chimericantigen-receptor-transduced T cells. Blood 119:2709-2720, 2012.
-
(2012)
Blood
, vol.119
, pp. 2709-2720
-
-
Kochenderfer, J.N.1
Dudley, M.E.2
Feldman, S.A.3
Wilson, W.H.4
Spaner, D.E.5
Maric, I.6
Stetler-Stevenson, M.7
Phan, G.Q.8
Hughes, M.S.9
Sherry, R.M.10
Yang, J.C.11
Kammula, U.S.12
Devillier, L.13
Carpenter, R.14
Nathan, D.A.15
Morgan, R.A.16
Laurencot, C.17
Rosenberg, S.A.18
-
118
-
-
1642348370
-
Flow cytometric immunophenotypic analysis of 306 cases of multiple myeloma
-
Lin P, Owens R, Tricot G and Wilson CS: Flow cytometric immunophenotypic analysis of 306 cases of multiple myeloma. Am J Clin Pathol 121:482-488, 2004.
-
(2004)
Am J Clin Pathol
, vol.121
, pp. 482-488
-
-
Lin, P.1
Owens, R.2
Tricot, G.3
Wilson, C.S.4
-
119
-
-
78649899281
-
Cytokine-induced killer cells for cell therapy of acute myeloid leukemia: Improvement of their immune activity by expression of CD33-specific chimeric receptors
-
Marin V, Pizzitola I, Agostoni V, Attianese GM, Finney H, Lawson A, Pule M, Rousseau R, Biondi A and Biagi E: Cytokine-induced killer cells for cell therapy of acute myeloid leukemia: improvement of their immune activity by expression of CD33-specific chimeric receptors. Haematologica 95:2144-2152, 2010.
-
(2010)
Haematologica
, vol.95
, pp. 2144-2152
-
-
Marin, V.1
Pizzitola, I.2
Agostoni, V.3
Attianese, G.M.4
Finney, H.5
Lawson, A.6
Pule, M.7
Rousseau, R.8
Biondi, A.9
Biagi, E.10
-
120
-
-
84876163922
-
Targeting of acute myeloid leukaemia by cytokine-induced killer cells redirected with a novel CD123-specific chimeric antigen receptor
-
Tettamanti S, Marin V, Pizzitola I, Magnani CF, Giordano Attianese GM, Cribioli E, Maltese F, Galimberti S, Lopez AF, Biondi A and Bonnet D, Biagi E: Targeting of acute myeloid leukaemia by cytokine-induced killer cells redirected with a novel CD123-specific chimeric antigen receptor. Br J Haematol 161:389-401, 2013.
-
(2013)
Br J Haematol
, vol.161
, pp. 389-401
-
-
Tettamanti, S.1
Marin, V.2
Pizzitola, I.3
Magnani, C.F.4
Giordano Attianese, G.M.5
Cribioli, E.6
Maltese, F.7
Galimberti, S.8
Lopez, A.F.9
Biondi, A.10
Bonnet, D.11
Biagi, E.12
-
121
-
-
84887419384
-
Persistence and efficacy of second generation CAR T cell against the LeY antigen in acute myeloid leukemia
-
Ritchie DS, Neeson PJ, Khot A, Peinert S, Tai T, Tainton K, Chen K, Shin M, Wall DM, Hönemann D, Gambell P, Westerman DA, Haurat J, Westwood JA, Scott AM, Kravets L, Dickinson M, Trapani JA, Smyth MJ, Darcy PK, Kershaw MH and Prince HM: Persistence and efficacy of second generation CAR T cell against the LeY antigen in acute myeloid leukemia. Mol Ther 21:2122-2129, 2013.
-
(2013)
Mol Ther
, vol.21
, pp. 2122-2129
-
-
Ritchie, D.S.1
Neeson, P.J.2
Khot, A.3
Peinert, S.4
Tai, T.5
Tainton, K.6
Chen, K.7
Shin, M.8
Wall, D.M.9
Hönemann, D.10
Gambell, P.11
Westerman, D.A.12
Haurat, J.13
Westwood, J.A.14
Scott, A.M.15
Kravets, L.16
Dickinson, M.17
Trapani, J.A.18
Smyth, M.J.19
Darcy, P.K.20
Kershaw, M.H.21
Prince, H.M.22
more..
-
122
-
-
33644534148
-
Vaccines for tumour prevention
-
Lollini PL, Cavallo F, Forni PN and Forni G: Vaccines for tumour prevention. Nature Reviews Cancer 6, 204-216, 2006.
-
(2006)
Nature Reviews Cancer
, vol.6
, pp. 204-216
-
-
Lollini, P.L.1
Cavallo, F.2
Forni, P.N.3
Forni, G.4
-
124
-
-
84864662070
-
Multipeptide immune response to cancer vaccine IMA901 after single-dose cyclophosphamide associates with longer patient survival
-
Walter S, Weinschenk T, Stenzl A, Zdrojowy R, Pluzanska A, Szczylik C, Staehler M, Brugger W, Dietrich P Y, Mendrzyk R, Hilf N, Schoor O, Fritsche J, Mahr A, Maurer D, Vass V, Trautwein C, Lewandrowski P, Flohr C, Pohla H, Stanczak JJ, Bronte V, Mandruzzato S, Biedermann T, Pawelec G, Derhovanessian E, Yamagishi H, Miki T, Hongo F, Takaha N, Hirakawa K, Tanaka H, Stevanovic S, Frisch J, Mayer-Mokler A, Kirner A, Rammensee HG, Reinhardt C and Singh-Jasuja H: Multipeptide immune response to cancer vaccine IMA901 after single-dose cyclophosphamide associates with longer patient survival. Nat Med 18:1254-1261, 2012.
-
(2012)
Nat Med
, vol.18
, pp. 1254-1261
-
-
Walter, S.1
Weinschenk, T.2
Stenzl, A.3
Zdrojowy, R.4
Pluzanska, A.5
Szczylik, C.6
Staehler, M.7
Brugger, W.8
Dietrich, P.Y.9
Mendrzyk, R.10
Hilf, N.11
Schoor, O.12
Fritsche, J.13
Mahr, A.14
Maurer, D.15
Vass, V.16
Trautwein, C.17
Lewandrowski, P.18
Flohr, C.19
Pohla, H.20
Stanczak, J.J.21
Bronte, V.22
Mandruzzato, S.23
Biedermann, T.24
Pawelec, G.25
Derhovanessian, E.26
Yamagishi, H.27
Miki, T.28
Hongo, F.29
Takaha, N.30
Hirakawa, K.31
Tanaka, H.32
Stevanovic, S.33
Frisch, J.34
Mayer-Mokler, A.35
Kirner, A.36
Rammensee, H.G.37
Reinhardt, C.38
Singh-Jasuja, H.39
more..
-
125
-
-
84892365940
-
Checkpoint blocking antibodies in cancer immunotherapy
-
Kyi C and Postow MA: Checkpoint blocking antibodies in cancer immunotherapy. FEBS Lett 588:368-376, 2014.
-
(2014)
FEBS Lett
, vol.588
, pp. 368-376
-
-
Kyi, C.1
Postow, M.A.2
-
126
-
-
84879599112
-
At the bedside: CTLA-4- and PD-1-blocking antibodies in cancer immunotherapy
-
Callahan MK and Wolchok JD: At the bedside: CTLA-4- and PD-1-blocking antibodies in cancer immunotherapy. J Leukoc Biol 94:41-53, 2013.
-
(2013)
J Leukoc Biol
, vol.94
, pp. 41-53
-
-
Callahan, M.K.1
Wolchok, J.D.2
-
127
-
-
84877022722
-
Exploiting CTLA-4, PD-1 and PD-L1 to reactivate the host immune response against cancer
-
Quezada SA and Peggs KS: Exploiting CTLA-4, PD-1 and PD-L1 to reactivate the host immune response against cancer. Br J Cancer 108:1560-1565, 2013.
-
(2013)
Br J Cancer
, vol.108
, pp. 1560-1565
-
-
Quezada, S.A.1
Peggs, K.S.2
-
128
-
-
0033954256
-
The protein data bank (www.pbb.org)
-
Berman, HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN and Borne PE: The Protein Data Bank (www.pbb.org), Nucleic Acids Res 28:235-242, 2000.
-
(2000)
Nucleic Acids Res
, vol.28
, pp. 235-242
-
-
Berman, H.M.1
Westbrook, J.2
Feng, Z.3
Gilliland, G.4
Bhat, T.N.5
Weissig, H.6
Shindyalov, I.N.7
Borne, P.E.8
|